{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:04:36Z","timestamp":1791925476656,"version":"4.3.4"},"reference-count":205,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:p>The inactivation of programmed cell death has profound effects not only on the development but also on the overall integrity of multicellular organisms. Beside developmental abnormalities, it may lead to tumorigenesis, autoimmunity, and other serious health problems. Deregulated apoptosis may also be the leading cause of cancer therapy chemoresistance. Caspase family of cysteinyl-proteases plays the key role in the initiation and execution of programmed cell death. This review gives an overview of the role of caspases, their natural modulators like IAPs, FLIPs, and Smac\/Diablo in apoptosis and upon inactivation, and also in cancer development. Besides describing the basic mechanisms governing programmed cell death, a large part of this review is dedicated to previous studies that were focused on screening tumours for mutations within caspase genes as well as their regulators. The last part of this review discusses several emerging treatments that involve modulation of caspases and their regulators. Thus, we also highlight caspase cascade modulating experimental anticancer drugs like cFLIP-antagonist CDDO-Me; cIAP1 antagonists OSU-03012 and ME-BS; and XIAP small molecule antagonists 1396\u201311, 1396\u201312, 1396\u201328, triptolide, AEG35156, survivin\/Hsp90 antagonist shephedrin, and some of the direct activators of procaspase-3.<\/jats:p>","DOI":"10.1136\/jmg.2009.066944","type":"journal-article","created":{"date-parts":[[2009,6,8]],"date-time":"2009-06-08T20:13:18Z","timestamp":1244491998000},"page":"497-510","source":"Crossref","is-referenced-by-count":560,"title":["Apoptosis and cancer: mutations within caspase genes"],"prefix":"10.1136","volume":"46","author":[{"given":"S","family":"Ghavami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Ande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Yeganeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Eshraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Bus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kadkhoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wiechec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Halayko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Los","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2009,6,7]]},"reference":[{"key":"2025100520475964000_46.8.497.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1714"},{"key":"2025100520475964000_46.8.497.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-008-0023-4"},{"key":"2025100520475964000_46.8.497.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2008.08.003"},{"key":"2025100520475964000_46.8.497.4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4161\/cbt.240","article-title":"Imatinib (ST1571) provides only limited selectivity for CML cells and treatment might be complicated by silent BCR-ABL genes.","volume":"2","author":"Jiang","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"2025100520475964000_46.8.497.5","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03349"},{"key":"2025100520475964000_46.8.497.6","doi-asserted-by":"publisher","DOI":"10.1038\/ni1008-1099"},{"key":"2025100520475964000_46.8.497.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(04)00237-0"},{"key":"2025100520475964000_46.8.497.8","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20874"},{"key":"2025100520475964000_46.8.497.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80430-4"},{"key":"2025100520475964000_46.8.497.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1312"},{"key":"2025100520475964000_46.8.497.11","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1126903"},{"key":"2025100520475964000_46.8.497.12","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO-1 (Fas\/CD95)-associatedproteins from a death-inducing signaling complex (DISC) with the receptor.","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J"},{"key":"2025100520475964000_46.8.497.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1305"},{"key":"2025100520475964000_46.8.497.14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.14.7795"},{"key":"2025100520475964000_46.8.497.15","doi-asserted-by":"publisher","DOI":"10.1038\/35008667"},{"key":"2025100520475964000_46.8.497.16","unstructured":"Los M Panigrahi S Rashedi I Mandal S Stetefeld J Essmann F , Schulze-Osthoff K. Apoptin, a tumor-selective killer. Biochim Biophys Acta (in press, PMID: 19374922)."},{"key":"2025100520475964000_46.8.497.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80211-3"},{"key":"2025100520475964000_46.8.497.18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000284200"},{"key":"2025100520475964000_46.8.497.19","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.297"},{"key":"2025100520475964000_46.8.497.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00129.x"},{"key":"2025100520475964000_46.8.497.21","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0903435"},{"key":"2025100520475964000_46.8.497.22","first-page":"7","article-title":"Cytotoxicity effect of Cladribine on the MCF-7 human breast cancer cell line.","volume":"8","author":"Hashemi","year":"2004","journal-title":"Iranian Biomed J"},{"key":"2025100520475964000_46.8.497.23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20947"},{"key":"2025100520475964000_46.8.497.24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbamcr.2007.10.015","article-title":"S100A8\/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac\/DIABLO and Omi\/HtrA2.","volume":"1783","author":"Ghavami","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"2025100520475964000_46.8.497.25","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.3.178"},{"key":"2025100520475964000_46.8.497.26","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022945107762"},{"key":"2025100520475964000_46.8.497.27","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.4835"},{"key":"2025100520475964000_46.8.497.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(01)01844-8"},{"key":"2025100520475964000_46.8.497.29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900003"},{"key":"2025100520475964000_46.8.497.30","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1496"},{"key":"2025100520475964000_46.8.497.31","first-page":"82","article-title":"Caspases and cancer: mechanism of inactivation and new treatment modalities.","volume":"26","author":"Philchenkov","year":"2004","journal-title":"Exp Oncol"},{"key":"2025100520475964000_46.8.497.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80434-1"},{"key":"2025100520475964000_46.8.497.33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400527"},{"key":"2025100520475964000_46.8.497.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00008-8"},{"key":"2025100520475964000_46.8.497.35","doi-asserted-by":"publisher","DOI":"10.1038\/nsb795"},{"key":"2025100520475964000_46.8.497.36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401088"},{"key":"2025100520475964000_46.8.497.37","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-003-0474-8"},{"key":"2025100520475964000_46.8.497.38","doi-asserted-by":"publisher","DOI":"10.1038\/375081a0"},{"key":"2025100520475964000_46.8.497.39","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90485-9"},{"key":"2025100520475964000_46.8.497.40","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80062-X"},{"key":"2025100520475964000_46.8.497.41","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401061"},{"key":"2025100520475964000_46.8.497.42","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5315"},{"key":"2025100520475964000_46.8.497.43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207107"},{"key":"2025100520475964000_46.8.497.44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.5.2976"},{"key":"2025100520475964000_46.8.497.45","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(00)01814-7"},{"key":"2025100520475964000_46.8.497.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.05.004"},{"key":"2025100520475964000_46.8.497.47","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6554-5_2"},{"key":"2025100520475964000_46.8.497.48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.29.20049"},{"key":"2025100520475964000_46.8.497.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellbi.2005.04.001"},{"key":"2025100520475964000_46.8.497.50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401340"},{"key":"2025100520475964000_46.8.497.51","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200209004"},{"key":"2025100520475964000_46.8.497.52","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095432"},{"key":"2025100520475964000_46.8.497.53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.20.13134"},{"key":"2025100520475964000_46.8.497.54","first-page":"615","article-title":"CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL\/tumor necrosis factor receptor-interacting protein RIP.","volume":"57","author":"Ahmad","year":"1997","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401033"},{"key":"2025100520475964000_46.8.497.56","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.149.3.603"},{"key":"2025100520475964000_46.8.497.57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M211512200"},{"key":"2025100520475964000_46.8.497.58","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E05-12-1107"},{"key":"2025100520475964000_46.8.497.59","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108029200"},{"key":"2025100520475964000_46.8.497.60","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400153"},{"key":"2025100520475964000_46.8.497.61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210635"},{"key":"2025100520475964000_46.8.497.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2006.11.030"},{"key":"2025100520475964000_46.8.497.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2006.05.017"},{"key":"2025100520475964000_46.8.497.64","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamcr.2009.01.002","article-title":"Role of BNIP3 in TNF-induced cell death - TNF upregulates BNIP3 expression.","volume":"1793","author":"Ghavami","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2025100520475964000_46.8.497.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.04.018"},{"key":"2025100520475964000_46.8.497.66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.42.27084"},{"key":"2025100520475964000_46.8.497.67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.21.012704.131040"},{"key":"2025100520475964000_46.8.497.68","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80223-9"},{"key":"2025100520475964000_46.8.497.69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206882200"},{"key":"2025100520475964000_46.8.497.70","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf356"},{"key":"2025100520475964000_46.8.497.71","doi-asserted-by":"publisher","DOI":"10.1038\/40657"},{"key":"2025100520475964000_46.8.497.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80501-2"},{"key":"2025100520475964000_46.8.497.73","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.24.3179"},{"key":"2025100520475964000_46.8.497.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80434-1"},{"key":"2025100520475964000_46.8.497.75","doi-asserted-by":"publisher","DOI":"10.1038\/21124"},{"key":"2025100520475964000_46.8.497.76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105102200"},{"key":"2025100520475964000_46.8.497.77","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M414358200"},{"key":"2025100520475964000_46.8.497.78","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf441"},{"key":"2025100520475964000_46.8.497.79","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00289-9"},{"key":"2025100520475964000_46.8.497.80","doi-asserted-by":"publisher","DOI":"10.1038\/47513"},{"key":"2025100520475964000_46.8.497.81","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.150.4.887"},{"key":"2025100520475964000_46.8.497.82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7270.2005.00108.x"},{"key":"2025100520475964000_46.8.497.83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204973200"},{"key":"2025100520475964000_46.8.497.84","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102225200"},{"key":"2025100520475964000_46.8.497.85","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200310015"},{"key":"2025100520475964000_46.8.497.86","first-page":"308","article-title":"Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system.","volume":"53","author":"Hauff","year":"2005","journal-title":"Arch Immunol Ther Exp"},{"key":"2025100520475964000_46.8.497.87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.158.1.163","article-title":"IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.","volume":"158","author":"Smith","year":"1997","journal-title":"J Immunol"},{"key":"2025100520475964000_46.8.497.88","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V91.6.2118","article-title":"Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice.","volume":"91","author":"Fantuzzi","year":"1998","journal-title":"Blood"},{"key":"2025100520475964000_46.8.497.89","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1"},{"key":"2025100520475964000_46.8.497.90","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401087"},{"key":"2025100520475964000_46.8.497.91","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400476"},{"key":"2025100520475964000_46.8.497.92","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008363200"},{"key":"2025100520475964000_46.8.497.93","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh270"},{"key":"2025100520475964000_46.8.497.94","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/0008-5472.815.65.3","article-title":"CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas.","volume":"65","author":"Soung","year":"2005","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.95","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206044"},{"key":"2025100520475964000_46.8.497.96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401157"},{"key":"2025100520475964000_46.8.497.97","doi-asserted-by":"publisher","DOI":"10.1038\/ng1981"},{"key":"2025100520475964000_46.8.497.98","doi-asserted-by":"crossref","unstructured":"Haiman CA Garcia RR Kolonel LN Henderson BE Wu AH Le Marchand L . A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet 2008;40:259\u201360; author reply 60\u20131.","DOI":"10.1038\/ng0308-259"},{"key":"2025100520475964000_46.8.497.99","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010213"},{"key":"2025100520475964000_46.8.497.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.08.010"},{"key":"2025100520475964000_46.8.497.101","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-007-9152-z"},{"key":"2025100520475964000_46.8.497.102","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0314"},{"key":"2025100520475964000_46.8.497.103","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0177"},{"key":"2025100520475964000_46.8.497.104","doi-asserted-by":"crossref","unstructured":"Schwartzbaum JA Fisher JL Aldape KD Wrensch M . Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006;2:494\u2013503; quiz 1 p following 16.","DOI":"10.1038\/ncpneuro0289"},{"key":"2025100520475964000_46.8.497.105","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgm014"},{"key":"2025100520475964000_46.8.497.106","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2807"},{"key":"2025100520475964000_46.8.497.107","doi-asserted-by":"publisher","DOI":"10.1038\/ng2030"},{"key":"2025100520475964000_46.8.497.108","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9752-z"},{"key":"2025100520475964000_46.8.497.109","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji001"},{"key":"2025100520475964000_46.8.497.110","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.12.1433"},{"key":"2025100520475964000_46.8.497.111","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9586-8"},{"key":"2025100520475964000_46.8.497.112","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-005-0032-0"},{"key":"2025100520475964000_46.8.497.113","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1669"},{"key":"2025100520475964000_46.8.497.114","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2025100520475964000_46.8.497.115","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15841-8"},{"key":"2025100520475964000_46.8.497.116","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: a population-based study.","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"2025100520475964000_46.8.497.117","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh161"},{"key":"2025100520475964000_46.8.497.118","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3748\/wjg.v12.i14.2229","article-title":"Establishment of risk model for pancreatic cancer in Chinese Han population.","volume":"12","author":"Lu","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2025100520475964000_46.8.497.119","doi-asserted-by":"publisher","DOI":"10.2188\/jea.15.S157"},{"key":"2025100520475964000_46.8.497.120","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10549"},{"key":"2025100520475964000_46.8.497.121","first-page":"33","article-title":"Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.","volume":"18","author":"Elnemr","year":"2001","journal-title":"Int J Oncol"},{"key":"2025100520475964000_46.8.497.122","first-page":"1741","article-title":"Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.","volume":"58","author":"Ungefroren","year":"1998","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.123","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81476-2"},{"key":"2025100520475964000_46.8.497.124","doi-asserted-by":"publisher","DOI":"10.2174\/092986707782793952"},{"key":"2025100520475964000_46.8.497.125","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600111"},{"key":"2025100520475964000_46.8.497.126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2006.apm_364.x"},{"key":"2025100520475964000_46.8.497.127","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl119"},{"key":"2025100520475964000_46.8.497.128","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh187"},{"key":"2025100520475964000_46.8.497.129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<1::AID-IJC1>3.0.CO;2-Y","article-title":"Molecular epidemiology: low-dose carcinogens and genetic susceptibility.","volume":"71","author":"Vineis","year":"1997","journal-title":"Int J Cancer"},{"key":"2025100520475964000_46.8.497.130","doi-asserted-by":"publisher","DOI":"10.1002\/hon.852"},{"key":"2025100520475964000_46.8.497.131","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(07)00420-4"},{"key":"2025100520475964000_46.8.497.132","first-page":"33","article-title":"Alteration of caspase-3 (CPP32\/Yama\/apopain) in wild-type MCF-7, breast cancer cells.","volume":"6","author":"Kurokawa","year":"1999","journal-title":"Oncol Rep"},{"key":"2025100520475964000_46.8.497.133","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00439-004-1129-3","article-title":"Somatic mutations of CASP3 gene in human cancers.","volume":"115","author":"Soung","year":"2004","journal-title":"Hum Genet"},{"key":"2025100520475964000_46.8.497.134","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1198"},{"key":"2025100520475964000_46.8.497.135","doi-asserted-by":"publisher","DOI":"10.1177\/154405910708600202"},{"key":"2025100520475964000_46.8.497.136","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.7.3228"},{"key":"2025100520475964000_46.8.497.137","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115035"},{"key":"2025100520475964000_46.8.497.138","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.3.1621"},{"key":"2025100520475964000_46.8.497.139","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206727"},{"key":"2025100520475964000_46.8.497.140","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00272-0"},{"key":"2025100520475964000_46.8.497.141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.09.003"},{"key":"2025100520475964000_46.8.497.142","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.10.015"},{"key":"2025100520475964000_46.8.497.143","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood.V90.8.3118","article-title":"Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE\/Ced-3 proteases).","volume":"90","author":"Los","year":"1997","journal-title":"Blood"},{"key":"2025100520475964000_46.8.497.144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2008.11.016"},{"key":"2025100520475964000_46.8.497.145","first-page":"5386","article-title":"Immunohistochemical localization of caspase-3 correlates with clinical outcome in B-cell diffuse large-cell lymphoma.","volume":"59","author":"Donoghue","year":"1999","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.146","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V96.12.3922","article-title":"Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.","volume":"96","author":"Svingen","year":"2000","journal-title":"Blood"},{"key":"2025100520475964000_46.8.497.147","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.711"},{"key":"2025100520475964000_46.8.497.148","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-007-9188-x"},{"key":"2025100520475964000_46.8.497.149","doi-asserted-by":"publisher","DOI":"10.1159\/000076403"},{"key":"2025100520475964000_46.8.497.150","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2465"},{"key":"2025100520475964000_46.8.497.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.02.003"},{"key":"2025100520475964000_46.8.497.152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4020-6554-5_7","article-title":"Trail receptors: targets for cancer therapy.","volume":"615","author":"Humphreys","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"2025100520475964000_46.8.497.153","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207232"},{"key":"2025100520475964000_46.8.497.154","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203816"},{"key":"2025100520475964000_46.8.497.155","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(03)00125-0"},{"key":"2025100520475964000_46.8.497.156","doi-asserted-by":"publisher","DOI":"10.1038\/75007"},{"key":"2025100520475964000_46.8.497.157","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.1.19"},{"key":"2025100520475964000_46.8.497.158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02723.x"},{"key":"2025100520475964000_46.8.497.159","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.6.10.4763"},{"key":"2025100520475964000_46.8.497.160","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.53.1.577"},{"key":"2025100520475964000_46.8.497.161","doi-asserted-by":"publisher","DOI":"10.1038\/nrm830"},{"key":"2025100520475964000_46.8.497.162","first-page":"19","article-title":"Viral modulation of cell death by inhibition of caspases.","volume":"51","author":"Cassens","year":"2003","journal-title":"Arch Immunol Ther Exp"},{"key":"2025100520475964000_46.8.497.163","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400795"},{"key":"2025100520475964000_46.8.497.164","first-page":"1796","article-title":"Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.","volume":"6","author":"Tamm","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2025100520475964000_46.8.497.165","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021915124064"},{"key":"2025100520475964000_46.8.497.166","first-page":"78","article-title":"Expression of survivin, cyclinD1, p21(WAF1), caspase-3 in cervical cancer and its relation with prognosis.","volume":"25","author":"Lu","year":"2005","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2025100520475964000_46.8.497.167","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-45"},{"key":"2025100520475964000_46.8.497.168","first-page":"2462","article-title":"Regulation of microtubule stability and mitotic progression by survivin.","volume":"62","author":"Giodini","year":"2002","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.169","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.302"},{"key":"2025100520475964000_46.8.497.170","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0136"},{"key":"2025100520475964000_46.8.497.171","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3898"},{"key":"2025100520475964000_46.8.497.172","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-091504"},{"key":"2025100520475964000_46.8.497.173","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M709525200"},{"key":"2025100520475964000_46.8.497.174","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-60"},{"key":"2025100520475964000_46.8.497.175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm735","article-title":"Smac agonists sensitize for Apo2L\/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.","volume":"8","author":"Fulda","year":"2002","journal-title":"Nat Med"},{"key":"2025100520475964000_46.8.497.176","first-page":"831","article-title":"Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.","volume":"63","author":"Yang","year":"2003","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.177","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207578200"},{"key":"2025100520475964000_46.8.497.178","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0608"},{"key":"2025100520475964000_46.8.497.179","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3168"},{"key":"2025100520475964000_46.8.497.180","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0634"},{"key":"2025100520475964000_46.8.497.181","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.02.011"},{"key":"2025100520475964000_46.8.497.182","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2434345100"},{"key":"2025100520475964000_46.8.497.183","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.035"},{"key":"2025100520475964000_46.8.497.184","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4161\/cbt.7.7.6100","article-title":"Survivin knockdown combined with apoptin overexpression inhibits cell growth significantly.","volume":"7","author":"Liu","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"2025100520475964000_46.8.497.185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4161\/cbt.7.7.6492","article-title":"The art of killing: double stroke with apoptin and survivin as a novel approach in cancer therapy.","volume":"7","author":"Panigrahi","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"2025100520475964000_46.8.497.186","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12082.x"},{"key":"2025100520475964000_46.8.497.187","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207071"},{"key":"2025100520475964000_46.8.497.188","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700531"},{"key":"2025100520475964000_46.8.497.189","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076807"},{"key":"2025100520475964000_46.8.497.190","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2003.11.013"},{"key":"2025100520475964000_46.8.497.191","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio814"},{"key":"2025100520475964000_46.8.497.192","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0778-02"},{"key":"2025100520475964000_46.8.497.193","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2007.01.003"},{"key":"2025100520475964000_46.8.497.194","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.009530"},{"key":"2025100520475964000_46.8.497.195","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.5.785"},{"key":"2025100520475964000_46.8.497.196","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.4094"},{"key":"2025100520475964000_46.8.497.197","first-page":"999","article-title":"Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis.","volume":"59","author":"Srinivasula","year":"1999","journal-title":"Cancer Res"},{"key":"2025100520475964000_46.8.497.198","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1593\/neo.08580","article-title":"The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.","volume":"10","author":"Glogowska","year":"2008","journal-title":"Neoplasia"},{"key":"2025100520475964000_46.8.497.199","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.11.010"},{"key":"2025100520475964000_46.8.497.200","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.07.050"},{"key":"2025100520475964000_46.8.497.201","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2007.00475.x"},{"key":"2025100520475964000_46.8.497.202","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210958"},{"key":"2025100520475964000_46.8.497.203","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0607397"},{"key":"2025100520475964000_46.8.497.204","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-008-0383-6"},{"key":"2025100520475964000_46.8.497.205","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-007-0025-7"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.2009.066944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T03:48:18Z","timestamp":1759722498000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.2009.066944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,7]]},"references-count":205,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,7,31]]},"published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1136\/jmg.2009.066944"],"URL":"https:\/\/doi.org\/10.1136\/jmg.2009.066944","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,7]]}}}